This file is provided for reference purposes only. It was current when it was produced, but it is no longer maintained and may now be out of date. Persons with disabilities having difficulty accessing information may contact us
for assistance. For reliable, current information on this and other health topics, we recommend consulting the NIH Clinical Center at http://www.cc.nih.gov/
for Organ and Tissue Transplantation
Allan D. Kirk, M.D.,
Chief, Transplantation Section
National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK)
For some patients, an organ or tissue
transplant means the difference between life and death. Even after
their operations, however, these patients face another danger:
Patients often need high doses of immunosuppressive
drugs to prevent their bodies from rejecting their new tissues.
But the unpleasant side effects of these drugs may cause patients
to stop taking them, virtually ensuring tissue rejection.
Dr. Allan D. Kirk, a surgeon and specialist
in transplantation, will speak about new ways to improve the success
of organ and tissue transplantation. He
began his undergraduate work at Boston University's School of
Fine Arts and finished it at Old Dominion Universityís
School of Sciences and Health Professions, earning a Bachelor
of Science. He went on to Duke University,
where he earned his medical degree and a doctorate in immunology.
Dr. Kirk joined the United States Navy
in 1983 with an Armed Forces Health Professions Scholarship. Currently,
he serves as a Commander in the Medical Corps of the Naval Reserves.
He did his internship and residency in surgery
at Duke University, becoming its Chief Resident in Surgery. Later,
he traveled to the University of
Wisconsin, where he was a Fellow in Transplantation and a research
scientist. Dr. Kirk continues his affiliation there as a Visiting
Assistant Professor of Surgery.
Since 1997, he has served as a principle
investigator with the Naval Medical Research Center and as an
attending surgeon with the Organ Transplant Service at Walter
Reed Army Medical Center.
In May of this year, he joined NIH as
Chief of the Transplantation Section in the National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Kirk
is the primary transplant surgeon for clinical trials being planned
in the new NIH Organ/Tissue Transplant Research Center, which
opened recently in the Clinical Center. Together with researchers
from the Naval Medical Research Center, NIDDK, and Walter Reed
Army Medical Center, he spearheads efforts to permit transplantation
without chronic immunosuppression.
Dr. Kirk has authored or coauthored articles
and book chapters on surgery and transplantation, and is a frequently
invited lecturer at scientific symposia. He
is a diplomate of the American Board of Surgery and an elected
member of the American Society of Transplant Surgeons, the American
Society of Transplant Physicians, and the Transplantation Society.
Central to his work is the belief that
tissue rejection can be reduced, so that patients need fewer immunosuppressive
drugs and can enjoy more trouble-free lives.
For more information
about the Clinical Center and its Medicine for the Public lecture
series, contact CC Communications (OCCC@nih.gov),
of Health, Warren Grant Magnuson Clinical Center, Bethesda, Maryland
Series | CC home | NIH home
The information on this page is archived and provided for reference purposes only.